Anticoagulation regimen during pregnancy | Maternal outcomes | Fetal/neonatal anticoagulant-related adverse events | Livebirth rate | |
Maternal mortality | Thromboembolism | |||
Vitamin K antagonist (INR target 2.5 to 3.5) | 0.9 (95% CI 0.1-1.6) | 2.7 (95% CI 1.4-4.0) | 2.0 (95% CI 0.3-3.7)* | 64.5 (95% CI 48.8-80.2) |
Sequential treatment | 2.0 (95% CI 0.8-3.1) | 5.8 (95% CI 3.8-7.7) | 1.4 (95% CI 0.3-2.5)¶ | 79.9 (95% CI 74.3-85.6) |
LMWH only (aPTT 1.5 to 2.5 × control) | 2.9 (95% CI 0.2-5.7) | 8.7 (95% CI 3.9-13.4) | 0 | 92.0 (95% CI 86.1-98.0) |
UFH only | 3.4 (95% CI 0-7.7) | 11.2 (95% CI 2.8-19.6) | 7.6 (95% CI 0.1-15.0)¶ | 69.5 (95% CI 37.8-100) |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟